Application of a Growth-Rate Model to Enhance Subgroup Identification in Heterogeneous Clinical Courses of the Idiopathic Inflammatory Myopathy-Associated Interstitial Lung Disease and Its Prognostic Implication

IF 2.4 4区 医学 Q2 RHEUMATOLOGY
Jiahao Tian, You-Jung Ha, Jeong Seok Lee, Eun Young Lee, Jonathan G. Goldin, Grace-Hyun J. Kim
{"title":"Application of a Growth-Rate Model to Enhance Subgroup Identification in Heterogeneous Clinical Courses of the Idiopathic Inflammatory Myopathy-Associated Interstitial Lung Disease and Its Prognostic Implication","authors":"Jiahao Tian,&nbsp;You-Jung Ha,&nbsp;Jeong Seok Lee,&nbsp;Eun Young Lee,&nbsp;Jonathan G. Goldin,&nbsp;Grace-Hyun J. Kim","doi":"10.1111/1756-185X.70320","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Analyzing longitudinal real-world data with nonuniform study-time intervals is challenging. This study aimed to identify subgroups in heterogeneous clinical courses of idiopathic inflammatory myopathies-associated interstitial lung disease (IIM-ILD) using a growth rate model and to assess their prognostic significance.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>In this retrospective cohort study, 243 chest high-resolution computed tomography (HRCT) scans from 80 patients with IIM-ILD were analyzed using a computer-aided quantification system to estimate quantitative lung fibrosis (QLF) scores. Longitudinal patterns were identified through a growth-rate model, and a landmark survival analysis was performed using the last HRCT date as an anchor.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Using the growth-rate model, we identified five different patterns in the serial QLF scores: progressive (<i>n</i> = 19), improving (<i>n</i> = 20), convex (<i>n</i> = 10), others (mostly concave, <i>n</i> = 22), and stable (<i>n</i> = 9). When the group with the progressive pattern was divided into the rapid progression and slow progression by the median progression rate (<b><i>g</i></b> = 1.029%/month), the rapid progressive group was significantly associated with mortality (Hazard ratio 15.926, 95% confidence interval 1.079–548.324, <i>p</i> = 0.043), compared to the reference group. However, the intensity of immunosuppression or QLF scores at landmark time were not associated with mortality.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Combined volumetric measurement of lung fibrosis and application of growth-rate model had the potential to identify subgroups in analyzing complex, dynamic real-world data of IIMs-ILD. This approach may help extrapolate the future course and provide useful information about prognosis in patients with ILD.</p>\n </section>\n </div>","PeriodicalId":14330,"journal":{"name":"International Journal of Rheumatic Diseases","volume":"28 6","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Rheumatic Diseases","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/1756-185X.70320","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Analyzing longitudinal real-world data with nonuniform study-time intervals is challenging. This study aimed to identify subgroups in heterogeneous clinical courses of idiopathic inflammatory myopathies-associated interstitial lung disease (IIM-ILD) using a growth rate model and to assess their prognostic significance.

Methods

In this retrospective cohort study, 243 chest high-resolution computed tomography (HRCT) scans from 80 patients with IIM-ILD were analyzed using a computer-aided quantification system to estimate quantitative lung fibrosis (QLF) scores. Longitudinal patterns were identified through a growth-rate model, and a landmark survival analysis was performed using the last HRCT date as an anchor.

Results

Using the growth-rate model, we identified five different patterns in the serial QLF scores: progressive (n = 19), improving (n = 20), convex (n = 10), others (mostly concave, n = 22), and stable (n = 9). When the group with the progressive pattern was divided into the rapid progression and slow progression by the median progression rate (g = 1.029%/month), the rapid progressive group was significantly associated with mortality (Hazard ratio 15.926, 95% confidence interval 1.079–548.324, p = 0.043), compared to the reference group. However, the intensity of immunosuppression or QLF scores at landmark time were not associated with mortality.

Conclusion

Combined volumetric measurement of lung fibrosis and application of growth-rate model had the potential to identify subgroups in analyzing complex, dynamic real-world data of IIMs-ILD. This approach may help extrapolate the future course and provide useful information about prognosis in patients with ILD.

应用生长速率模型在特发性炎性肌病相关间质性肺疾病的异质临床过程中增强亚组识别及其预后意义
分析具有非均匀研究时间间隔的纵向真实数据是具有挑战性的。本研究旨在使用生长速率模型确定特发性炎性肌病相关间质性肺疾病(IIM-ILD)异质性临床病程的亚群,并评估其预后意义。方法在这项回顾性队列研究中,使用计算机辅助量化系统对80例IIM-ILD患者的243张胸部高分辨率计算机断层扫描(HRCT)进行分析,以估计定量肺纤维化(QLF)评分。通过生长速率模型确定纵向模式,并使用最后一次HRCT日期作为锚点进行里程碑式生存分析。使用生长速率模型,我们确定了QLF评分序列的五种不同模式:进行性(n = 19),改善性(n = 20),凸性(n = 10),其他(主要是凹性,n = 22)和稳定(n = 9)。将进展型组按中位进展率(g = 1.029%/月)分为快速进展组和缓慢进展组,与对照组相比,快速进展组与死亡率显著相关(风险比15.926,95%可信区间1.079 ~ 548.324,p = 0.043)。然而,免疫抑制强度或里程碑时间的QLF评分与死亡率无关。结论肺纤维化的体积测量和生长速率模型的应用在分析IIMs-ILD复杂、动态的真实数据时具有识别亚群的潜力。这种方法可能有助于推断未来的病程,并为ILD患者的预后提供有用的信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.70
自引率
4.00%
发文量
362
审稿时长
1 months
期刊介绍: The International Journal of Rheumatic Diseases (formerly APLAR Journal of Rheumatology) is the official journal of the Asia Pacific League of Associations for Rheumatology. The Journal accepts original articles on clinical or experimental research pertinent to the rheumatic diseases, work on connective tissue diseases and other immune and allergic disorders. The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are peer reviewed by two anonymous reviewers and the Editor.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信